实用药物与临床
實用藥物與臨床
실용약물여림상
PRACTICAL PHARMACY AND CLINICAL REMEDIES
2015年
4期
415-417
,共3页
张贺洋%于锦香%颜晓菁%张蕊%高然%王玥%俞钦川%李艳
張賀洋%于錦香%顏曉菁%張蕊%高然%王玥%俞欽川%李豔
장하양%우금향%안효정%장예%고연%왕모%유흠천%리염
急性早幼粒细胞白血病%全反式维甲酸%三氧化二砷%血脂异常
急性早幼粒細胞白血病%全反式維甲痠%三氧化二砷%血脂異常
급성조유립세포백혈병%전반식유갑산%삼양화이신%혈지이상
Acute promyelocytic leukemia%All-trans retinoic acid%Arsenic trioxide%Dyslipidemia
目的:探讨全反式维甲酸( ATRA)联合三氧化二砷( ATO)治疗急性早幼粒细胞白血病( APL)过程中血清血脂的变化规律。方法回顾分析经全反式维甲酸联合三氧化二砷诱导完全缓解后,两种药物联合巩固治疗2个周期的急性早幼粒细胞白血病住院患者49例。分别于治疗前、完全缓解后( CR)、联合用药巩固治疗第1个周期结束及第2周期结束,检测血清血脂指标-血清三酰甘油( TG)、血清总胆固醇( TC)。并对血脂指标进行统计学分析。结果经ATRA联合ATO治疗完全缓解后,患者血脂与治疗前比较,差异无统计学意义( P>0.05)。完全缓解后巩固治疗1个周期,血清TG及TC 水平升高(P<0.05)。完全缓解后巩固治疗2个周期,分别与治疗前、完全缓解后及巩固治疗1个周期比较,血清TG及TC升高( P<0.01)。结论 APL患者经AT-RA联合ATO治疗会导致血脂升高。
目的:探討全反式維甲痠( ATRA)聯閤三氧化二砷( ATO)治療急性早幼粒細胞白血病( APL)過程中血清血脂的變化規律。方法迴顧分析經全反式維甲痠聯閤三氧化二砷誘導完全緩解後,兩種藥物聯閤鞏固治療2箇週期的急性早幼粒細胞白血病住院患者49例。分彆于治療前、完全緩解後( CR)、聯閤用藥鞏固治療第1箇週期結束及第2週期結束,檢測血清血脂指標-血清三酰甘油( TG)、血清總膽固醇( TC)。併對血脂指標進行統計學分析。結果經ATRA聯閤ATO治療完全緩解後,患者血脂與治療前比較,差異無統計學意義( P>0.05)。完全緩解後鞏固治療1箇週期,血清TG及TC 水平升高(P<0.05)。完全緩解後鞏固治療2箇週期,分彆與治療前、完全緩解後及鞏固治療1箇週期比較,血清TG及TC升高( P<0.01)。結論 APL患者經AT-RA聯閤ATO治療會導緻血脂升高。
목적:탐토전반식유갑산( ATRA)연합삼양화이신( ATO)치료급성조유립세포백혈병( APL)과정중혈청혈지적변화규률。방법회고분석경전반식유갑산연합삼양화이신유도완전완해후,량충약물연합공고치료2개주기적급성조유립세포백혈병주원환자49례。분별우치료전、완전완해후( CR)、연합용약공고치료제1개주기결속급제2주기결속,검측혈청혈지지표-혈청삼선감유( TG)、혈청총담고순( TC)。병대혈지지표진행통계학분석。결과경ATRA연합ATO치료완전완해후,환자혈지여치료전비교,차이무통계학의의( P>0.05)。완전완해후공고치료1개주기,혈청TG급TC 수평승고(P<0.05)。완전완해후공고치료2개주기,분별여치료전、완전완해후급공고치료1개주기비교,혈청TG급TC승고( P<0.01)。결론 APL환자경AT-RA연합ATO치료회도치혈지승고。
Objective To explore the changes of serum lipid of acute promyelocytic leukemia ( APL) treated by all-trans retinoic acid in combination with arsenic trioxide. Methods 49 hospitalized patients with acute promyelo-cytic leukemia who attained complete remission by using all-trans retinoic acid in combination with arsenic trioxide and then consolidated for two cycles were retrospectively analyzed. The index of serum lipid( serum triglycerides,serum to-tal cholesterol) were detected and statistical analysis was performed respectively before treatment,after complete remis-sion ( CR) ,at the end of the first and second cycle of combination consolidation treatment. Results After complete re-mission, no significant change was observed in the indexes of serum lipid (P>0. 05). At the end of the first cycle of combination consolidation treatment, the serum triglyceride and cholesterol increased (P<0. 05);and the indexes con-tinued to raise at the end of the second cycle of treatment (P<0. 01). Conclusion Patients with APL treated by AT-RA combined with ATO can lead to elevated blood lipids.